News

Patient Capital Management highlights Q2 winners like QXO and Nvidia, while exiting NFE over default risks. See what’s ...
Amid a cautious outlook, Biogen has presented new data at the Alzheimer’s Association International Conference (AAIC) 2025, demonstrating that investigational Leqembi 360 mg subcutaneous maintenance ...